Xometry, Inc. XMTR
109.01 USD -4.51 (-3.97%)
At closeNov 5, 2026, 4:46 PM EST
107.48 -1.53 -1.40%
After hours · Nov 5, 4:46 PM ET
103.93 Day range 113.45
35.86 52-week range 117.50
- YTD
- +83.30%
- 1 year
- +73.94%
Analyst view
Consensus: buy
Buy
Price target (mean) 116.18 +6.6% upside
Now 109.01
- Target (low)
- 95.00
- Target (mean)
- 116.18
- Target (high)
- 140.00
Ratings (0m) 12 9 buy · 3 hold · 0 sell
- Strong buy3
- Buy6
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 12
- 2 months ago 12
- 3 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.28599 | 0.28 – 0.30 | 0.16 | +78.7% | 247.79M | +28.8% | 4 |
| Next quarter | 0.26008 | 0.20 – 0.31 | 0.12 | +116.7% | 253.57M | +23.6% | 7 |
| Current year | 0.84432 | 0.83 – 0.86 | 0.38 | +122.2% | 942.55M | +37.3% | 4 |
| Next year | 1.33 | 1.11 – 1.50 | 0.84432 | +57.3% | 1.13B | +20.2% | 10 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 4, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 4, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Nov 4, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Nov 4, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Nov 4, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Nov 4, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Sep 22, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Sep 21, 2026 | Citizens | Reiterated | Market Outperform | Market Outperform |
| Aug 20, 2026 | Rosenblatt | Initiated | — | Buy |
| Aug 5, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 5, 2026 | Citigroup | Maintained | Buy | Buy |
| Aug 5, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Aug 5, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Aug 5, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| May 12, 2026 | Citigroup | Maintained | Buy | Buy |
| May 8, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| May 8, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Apr 30, 2026 | Cantor Fitzgerald | Upgrade | Neutral | Overweight |
| Feb 25, 2026 | UBS | Maintained | Neutral | Neutral |
| Feb 25, 2026 | Citigroup | Maintained | Buy | Buy |
| Feb 25, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Feb 25, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Nov 5, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 5, 2025 | Goldman Sachs | Maintained | Neutral | Neutral |
| Nov 5, 2025 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Nov 5, 2025 | Wedbush | Maintained | Outperform | Outperform |
| Nov 5, 2025 | Citizens | Maintained | Market Outperform | Market Outperform |
| Oct 16, 2025 | Goldman Sachs | Downgrade | Buy | Neutral |
| Aug 6, 2025 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Aug 6, 2025 | UBS | Maintained | Neutral | Neutral |
